Literature DB >> 32229275

Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients.

Maria L Espinosa1, Morgan T Nguyen1, Amaia Saenz Aguirre1, Maria Estela Martinez-Escala1, Jane Kim1, Christina J Walker1, David S Pontes1, Jonathan I Silverberg2, Jaehyuk Choi3, Barbara Pro4, Laura B Pincus5, Joan Guitart1, Xiaolong A Zhou6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32229275      PMCID： PMC7302979          DOI： 10.1016/j.jaad.2020.03.050

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.

Authors:  Emma Guttman-Yassky; Robert Bissonnette; Benjamin Ungar; Mayte Suárez-Fariñas; Marius Ardeleanu; Hitokazu Esaki; Maria Suprun; Yeriel Estrada; Hui Xu; Xiangyu Peng; Jonathan I Silverberg; Alan Menter; James G Krueger; Rick Zhang; Usman Chaudhry; Brian Swanson; Neil M H Graham; Gianluca Pirozzi; George D Yancopoulos; Jennifer D D Hamilton
Journal:  J Allergy Clin Immunol       Date:  2018-09-05       Impact factor: 10.793

Review 2.  Pruritus in Cutaneous T-Cell Lymphoma and Its Management.

Authors:  Linda Serrano; Maria Estela Martinez-Escala; Xiaolong A Zhou; Joan Guitart
Journal:  Dermatol Clin       Date:  2018-07       Impact factor: 3.478

Review 3.  Dupilumab: A review of its use in the treatment of atopic dermatitis.

Authors:  Melinda J Gooderham; H Chih-Ho Hong; Panteha Eshtiaghi; Kim A Papp
Journal:  J Am Acad Dermatol       Date:  2018-03       Impact factor: 11.527

Review 4.  Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover.

Authors:  Thorbjørn Krejsgaard; Lise M Lindahl; Nigel P Mongan; Mariusz A Wasik; Ivan V Litvinov; Lars Iversen; Erik Langhoff; Anders Woetmann; Niels Odum
Journal:  Semin Immunopathol       Date:  2016-10-07       Impact factor: 9.623

Review 5.  Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets.

Authors:  Ieva Saulite; Wolfram Hoetzenecker; Stephan Weidinger; Antonio Cozzio; Emmanuella Guenova; Ulrike Wehkamp
Journal:  Biomed Res Int       Date:  2016-05-17       Impact factor: 3.411
  5 in total
  10 in total

1.  Pipeline Perspectives and Therapy Updates.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2020-11-01

Review 2.  Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis.

Authors:  Kumi Nakazaki; Mina Yoshida; Yosuke Masamoto; Aya Shinozaki-Ushiku; Masako Ikemura; Teruyoshi Hisamoto; Megumi Yasunaga; Shinichi Sato; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2022-03-30       Impact factor: 2.319

Review 3.  The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication.

Authors:  Joseph S Durgin; David M Weiner; Maria Wysocka; Alain H Rook
Journal:  J Am Acad Dermatol       Date:  2020-12-22       Impact factor: 11.527

4.  Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case series.

Authors:  N A Trum; J Zain; X U Martinez; V Parekh; M Afkhami; F Abdulla; K R Carson; S T Rosen; C L Bennett; C Querfeld
Journal:  Br J Dermatol       Date:  2021-10-20       Impact factor: 9.302

5.  Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas.

Authors:  Ingrid Lazaridou; Caroline Ram-Wolff; Jean-David Bouaziz; Edouard Bégon; Maxime Battistella; Jacqueline Rivet; Marie Jachiet; Martine Bagot; Adèle de Masson
Journal:  Acta Derm Venereol       Date:  2020-09-30       Impact factor: 3.875

6.  Increased Regulatory T Cells and Decreased Myeloid-Derived Suppressor Cells Induced by High CCL17 Levels May Account for Normal Incidence of Cancers among Patients with Atopic Dermatitis.

Authors:  Sohshi Morimura; Makoto Sugaya; Tomonori Oka; Hiraku Suga; Tomomitsu Miyagaki; Yuichiro Tsunemi; Yoshihide Asano; Shinichi Sato
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

7.  Cutaneous T-cell lymphoma in SHOC2 mutation-associated Noonan-like syndrome with loose anagen hair.

Authors:  Alexandria Avery; John S Metcalf; John C Maize; Leah A Swanson
Journal:  JAAD Case Rep       Date:  2022-04-26

8.  Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash.

Authors:  Nicholas A Trum; Jasmine Zain; Chelsea Abad; Steven T Rosen; Christiane Querfeld
Journal:  JAAD Case Rep       Date:  2021-06-09

9.  The Course of Mycosis Fungoides under Cytokine Pathway Blockers: A Multicentre Analysis of Real-life Clinical Data.

Authors:  Iris Amitay-Laish; Emmanuella Guenova; Pablo L Ortiz-Romero; Cristina Vico-Alonso; Sima Rozati; Larisa J Geskin; Vasiliki Nikolaou; Evangelia Papadavid; Aviv Barzilai; Lev Pavlovsky; Elena Didkovsky; Hadas Prag Naveh; Oleg E Akilov; Emmilia Hodak
Journal:  Acta Derm Venereol       Date:  2020-09-30       Impact factor: 3.875

Review 10.  Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas.

Authors:  Karol Kołkowski; Magdalena Trzeciak; Małgorzata Sokołowska-Wojdyło
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.